Getting Biotechs GlobalReady

From early to late phase with GlobalReady

Our proprietary GlobalReady model covers the entire drug development journey from robust early phase clinical foundations with ClinicReady to seamless multi-regional late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.

THREE decades of deep
clinical research management

GlobalReady offers decades of deep clinical research management experience across Australia, New Zealand, Asia, North America, and Europe. More than 90 biotech clients have already taken advantage of Avance Clinical’s GlobalReady program.

In addition, the attractive 43.5% rebate on clinical spend in Australia offers our clients the opportunity to start their pre-clinical and early phase trials quickly in Australia (no IND required), then expand to North America, Asia, and Europe for later phases.

This unique GlobalReady model is designed to extend biotechs’ investments so they can achieve greater clinical development milestones with reduced spend, all with the assurance of FDA-accepted data.

get in touch with our
clinical operations team

Delivering more than 30 years experience of drug development expertise

How GlobalReady delivers
across all phases

GlobalReady is designed to support biotechs from their early pre-clinical through to later phases.

All with the one CRO, across the globe, and leveraging the right site relationships and delivering access to patient populations.

WHY BIOTECHS CHOOSE
AVANCE CLINICAL

More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.

43.5%

REBATE

5-6 Wks

START-UP TIME

100%

CAPABILITIES

FDA

COMPLIANT RESEARCH